January 22, 2020January 22, 2020
Antibiotic Azithromycin Lessens Fibrosis, Promotes Death of IPF Fibroblasts, Study Reports
News
The antibiotic azithromycin (AZT), frequently prescribed for fighting bacterial infections, has anti-fibrotic effects and promotes the death of fibroblasts ... Read more
January 21, 2020January 22, 2020
Help Us Improve Our Site!
News
We are always trying to provide a better, more relevant website to meet the needs of our readers. The ... Read more
January 21, 2020January 22, 2020
Peroxiredoxin-4 May Be Useful Biomarker for Early Detection of Acute Exacerbations in IPF, Study Suggests
News
The protein peroxiredoxin-4 may be a useful blood marker in the early detection of acute exacerbation of idiopathic ... Read more
January 20, 2020January 17, 2020
It Takes a Village to Survive Pulmonary Fibrosis
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
You may be familiar with the proverb, “It takes a village to raise a child.” The phrase is believed ... Read more
January 20, 2020January 20, 2020
New Pulmonary Wellness Foundation Offers Free Online Rehab Programs
News
New York cardiopulmonary physical therapist Noah Greenspan has launched the Pulmonary Wellness Foundation (PWF), a nonprofit group that provides ... Read more
January 17, 2020January 15, 2020
Caregivers Need Care, Too
Columns, Courage to Care - a column by Christie Patient
I was recently brainstorming ideas with other rare disease columnists about how to support someone admitted for a long ... Read more
January 17, 2020January 17, 2020
Phase 2 Trial of Potential Oral Treatment for IPF Fully Enrolled, Galapagos Says
News
Galapagos NV announced that its Phase 2 PINTA trial, evaluating the safety and effectiveness of oral GLPG1205 in people with ... Read more
January 16, 2020January 14, 2020
My Latest Health Setback Left Me Feeling Overwhelmed with Guilt
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
You would be hard-pressed to find anyone who hates pulmonary fibrosis (PF) more than the patients living with it ... Read more
January 15, 2020January 15, 2020
In Its 10th Year, ‘Broadway Belts for PFF!’ Will Take Stage Feb. 24
News
Marking a decade of raising funds to battle pulmonary fibrosis (PF), this year’s glitzy and glamorous “Broadway Belts for PFF!” ... Read more
January 14, 2020January 14, 2020
Boehringer Ingelheim Acquires Enleofen’s Anti-IL-11 Therapeutic Platform for Fibrotic Diseases
News
Boehringer Ingelheim has acquired the worldwide exclusive rights to Enleofen‘s interleukin-11 (IL-11) platform, designed for the treatment of fibrotic ... Read more
January 13, 2020January 14, 2020
Being Vulnerable with a Chronic Illness Can Be Beneficial
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
One of my most vivid memories of my late friend Serena Lawrence is when we sat down to discuss my ... Read more
January 13, 2020January 13, 2020
Scholar Rock Receives $25M for Continued Research in Potential Therapies for Fibrotic Diseases
News
Biopharmaceutical company Scholar Rock received $25 million from Gilead Sciences to continue the development of potential therapies to treat ... Read more

January 22, 2020January 22, 2020

Antibiotic Azithromycin Lessens Fibrosis, Promotes Death of IPF Fibroblasts, Study Reports

News

The antibiotic azithromycin (AZT), frequently prescribed for fighting bacterial infections, has anti-fibrotic effects and promotes the death of fibroblasts — cells promoting fibrosis, or scarring — in people with ... Read more

January 21, 2020January 22, 2020

Help Us Improve Our Site!

News

We are always trying to provide a better, more relevant website to meet the needs of our readers. The best way to do that is to hear from people ... Read more

January 21, 2020January 22, 2020

Peroxiredoxin-4 May Be Useful Biomarker for Early Detection of Acute Exacerbations in IPF, Study Suggests

News

The protein peroxiredoxin-4 may be a useful blood marker in the early detection of acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF), a study has found. The finding was described ... Read more

January 20, 2020January 17, 2020

It Takes a Village to Survive Pulmonary Fibrosis

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

You may be familiar with the proverb, “It takes a village to raise a child.” The phrase is believed to have originated from the Nigerian Igbo culture and is ... Read more

January 20, 2020January 20, 2020

New Pulmonary Wellness Foundation Offers Free Online Rehab Programs

News

New York cardiopulmonary physical therapist Noah Greenspan has launched the Pulmonary Wellness Foundation (PWF), a nonprofit group that provides free online information on a range of prevalent, rare and ... Read more

January 17, 2020January 15, 2020

Caregivers Need Care, Too

Columns, Courage to Care - a column by Christie Patient

I was recently brainstorming ideas with other rare disease columnists about how to support someone admitted for a long hospital stay. I started thinking about the ways that caregivers ... Read more

January 17, 2020January 17, 2020

Phase 2 Trial of Potential Oral Treatment for IPF Fully Enrolled, Galapagos Says

News

Galapagos NV announced that its Phase 2 PINTA trial, evaluating the safety and effectiveness of oral GLPG1205 in people with idiopathic pulmonary fibrosis (IPF), has completed patient recruitment ahead of ... Read more

January 16, 2020January 14, 2020

My Latest Health Setback Left Me Feeling Overwhelmed with Guilt

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

You would be hard-pressed to find anyone who hates pulmonary fibrosis (PF) more than the patients living with it and their caregivers. This chronic and debilitating disease, characterized by ... Read more

January 15, 2020January 15, 2020

In Its 10th Year, ‘Broadway Belts for PFF!’ Will Take Stage Feb. 24

News

Marking a decade of raising funds to battle pulmonary fibrosis (PF), this year’s glitzy and glamorous “Broadway Belts for PFF!” event will be held on Feb. 24 in New York ... Read more

January 14, 2020January 14, 2020

Boehringer Ingelheim Acquires Enleofen’s Anti-IL-11 Therapeutic Platform for Fibrotic Diseases

News

Boehringer Ingelheim has acquired the worldwide exclusive rights to Enleofen‘s interleukin-11 (IL-11) platform, designed for the treatment of fibrotic diseases such as pulmonary fibrosis. This newly established partnership brings ... Read more

January 13, 2020January 14, 2020

Being Vulnerable with a Chronic Illness Can Be Beneficial

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

One of my most vivid memories of my late friend Serena Lawrence is when we sat down to discuss my becoming a columnist for BioNews Services. I’d just been diagnosed ... Read more

January 13, 2020January 13, 2020

Scholar Rock Receives $25M for Continued Research in Potential Therapies for Fibrotic Diseases

News

Biopharmaceutical company Scholar Rock received $25 million from Gilead Sciences to continue the development of potential therapies to treat the progression of fibrotic diseases, including pulmonary fibrosis (PF). This ... Read more